Literature DB >> 2534971

Atrial natriuretic peptide and sodium homeostasis in chronic renal failure.

T Tulassay1, W Rascher, K Schärer.   

Abstract

In order to evaluate the possible role of vasoactive hormones in the mechanism of exaggerated sodium loss due to reduced renal mass we measured plasma concentration of atrial natriuretic peptide (ANP), aldosterone, plasma renin activity (PRA), plasma noradrenaline, and dopamine, in 12 children with advanced chronic renal failure (mean CIn 17.8 +/- 2.6, mean +/- SEM, CPAH 93.5 +/- 17 ml/min per 1.73 m2, FENa 7.0 +/- 0.95%). No patient had clinical signs of volume overload. Plasma concentrations of ANP were not significantly different from those of healthy age-matched controls (29.2 +/- 7.2 vs 23.2 +/- 3.1 fmol/ml) and did not correlate with urinary sodium excretion. Plasma concentrations of aldosterone, PRA and noradrenaline, were also within the physiological range, while plasma dopamine levels were elevated (260 +/- 36 vs 98 +/- 11 pg/ml, less than 0.001). Our data do not support the notion that ANP or the renin-aldosterone axis play a major role in the adaptation of remaining nephrons to maintain long-term sodium balance in normotensive children with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2534971     DOI: 10.1007/bf00850214

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  29 in total

1.  No evidence for product inhibition of the renin-angiotensinogen reaction in the rat.

Authors:  E Hackenthal; R Hackenthal; K G Hofbauer
Journal:  Circ Res       Date:  1977-10       Impact factor: 17.367

2.  Atrial natriuretic peptide in infants and children.

Authors:  W Rascher; M Bald; J Kreis; T Tulassay; U Heinrich; K Schärer
Journal:  Horm Res       Date:  1987

Review 3.  The control of sodium excretion with normal and reduced nephron populations. The pre-eminence of third factor.

Authors:  N S Bricker
Journal:  Am J Med       Date:  1967-09       Impact factor: 4.965

4.  Failure of renal dopamine response to salt loading in chronic renal disease.

Authors:  I F Casson; M R Lee; A M Brownjohn; F M Parsons; A M Davison; E J Will; A D Clayden
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

5.  Sodium homeostasis in chronic renal disease.

Authors: 
Journal:  Kidney Int       Date:  1982-06       Impact factor: 10.612

6.  On the adaptation in sodium excretion in chronic uremia. The effects of "proportional reduction" of sodium intake.

Authors:  R W Schmidt; J J Bourgoignie; N S Bricker
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

7.  Vasoactive hormones in children with chronic renal failure.

Authors:  W Rauh; E Hund; G Sohl; W Rascher; O Mehls; K Schärer
Journal:  Kidney Int Suppl       Date:  1983-11       Impact factor: 10.545

8.  The plasma release of atrial natriuretic peptide in man.

Authors:  J V Anderson; J Donckier; W J McKenna; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1986-08       Impact factor: 6.124

9.  Comparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseases.

Authors:  J Weil; F Bidlingmaier; C Döhlemann; U Kuhnle; T Strom; R E Lang
Journal:  Pediatr Res       Date:  1986-12       Impact factor: 3.756

10.  Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure.

Authors:  T Eisenhauer; J Talartschik; F Scheler
Journal:  Klin Wochenschr       Date:  1986
View more
  1 in total

1.  Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.

Authors:  B Lettgen; M Bald; H Valleé; K E Bonzel; W Rascher
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.